uBriGene
uBriGene is driven by the advancement of gene and cell therapy technologies through research and development.
uBriGene is a company in biotechnology based in Asia-Pacific (APAC), founded in 2015.
Within the biotechnology space, the company focuses on its core offering rather than a broad product line.
Asia-Pacific (APAC) is where the company is located.
The company is listed at the Series_C stage of development.
Recorded headcount: c_00501_01000 employees.
Total disclosed funding stands at about $68M.
| Sector | Biotechnology |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2015 |
| Employees | c_00501_01000 |
| Stage | series_c |
| Total funding | $67,965,132 |
Website: www.ubrigene.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account